Home > Insider Trading > Filing (0001209191-21-009047)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1785345	Landos Biopharma Inc.	LABP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1678736	Konstantin Poukalov	C/O Landos Biopharma, Inc. 1800 Kraft Drive, Suite 216 Blacksburg VA 24060		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-02-05	27,453	$11.14	14,647,181	No	4	P	Indirect	By funds
Common Stock	Acquisiton	2021-02-08	34,611	$11.38	14,681,792	No	4	P	Indirect	By funds
Common Stock	Acquisiton	2021-02-08	86,671	$12.53	14,768,463	No	4	P	Indirect	By funds
Common Stock	Acquisiton	2021-02-08	1,771	$13.10	14,770,234	No	4	P	Indirect	By funds
Common Stock	Acquisiton	2021-02-09	64,730	$13.80	14,834,964	No	4	P	Indirect	By funds
Common Stock	Acquisiton	2021-02-09	34,951	$14.60	14,869,915	No	4	P	Indirect	By funds

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By funds
No	4	P	Indirect	By funds
No	4	P	Indirect	By funds
No	4	P	Indirect	By funds
No	4	P	Indirect	By funds
No	4	P	Indirect	By funds

Footnotes

The prices reported in Column 4 are weighted average prices. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges of the prices reported on this Form 4.
These shares were purchased in multiple transactions at prices ranging from $11.05 to $11.75, inclusive.
Securities are held by Perceptive Life Sciences Master Fund, Ltd. ("PLSMF"), Perceptive Xontogeny Venture Fund, LP ("PXVF"), and PX Venture (A), LLC ("PXV"). Perceptive Advisors, LLC ("Perceptive Advisors") serves as the investment manager to PLSMF, PXVF, and PXV. The Reporting Person is a managing director of Perceptive Advisors. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
These shares were purchased in multiple transactions at prices ranging from $10.96 to $11.93, inclusive.
These shares were purchased in multiple transactions at prices ranging from $11.96 to $12.95, inclusive.
These shares were purchased in multiple transactions at prices ranging from $13.09 to $13.10, inclusive.
These shares were purchased in multiple transactions at prices ranging from $13.17 to $14.16, inclusive.
These shares were purchased in multiple transactions at prices ranging from $14.17 to $15.20, inclusive.